PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Recombinant Proteins Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran 1517964311, Iran.\', \'Department of Pathology & Laboratory Medicine, Center for Mitochondrial & Epigenomic Medicine, Children\'s Hospital of Philadelphia, Philadelphia, PA 19104, USA; Department of Pathology & Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.\', \'Division of Infectious Diseases, Department of Pediatrics, Boston Children\'s Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.\', \'Recombinant Proteins Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran 1517964311, Iran. Electronic address: laylafarahmand@gmail.com.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1567-5769(20)33638-910.1016/j.intimp.2020.107171
?:hasPublicationType
?:journal
  • International immunopharmacology
is ?:pmid of
?:pmid
?:pmid
  • 33221168
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.051
?:rankingScore_hIndex
  • 94
is ?:relation_isRelatedTo_publication of
?:title
  • Potential role of interferons in treating COVID-19 patients.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all